Edward Pequignot

6.6k total citations · 1 hit paper
49 papers, 2.5k citations indexed

About

Edward Pequignot is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edward Pequignot has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 9 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edward Pequignot's work include CAR-T cell therapy research (10 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Edward Pequignot is often cited by papers focused on CAR-T cell therapy research (10 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Edward Pequignot collaborates with scholars based in United States, Germany and Canada. Edward Pequignot's co-authors include Walter W. Hauck, Walter J. Curran, Maria Werner‐Wasik, Carl H. June, Daniel Monti, Simon F. Lacey, Caroline Peterson, Lora Rhodes, E Kunkel and Noelle V. Frey and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Edward Pequignot

48 papers receiving 2.4k citations

Hit Papers

Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T ... 2015 2026 2018 2022 2015 100 200 300 400

Peers

Edward Pequignot
April Coan United States
Frances McSherry United States
Olav Dahl Norway
Simon J. Hall United States
Marc Klein France
Jang‐Hee Kim South Korea
Miriam Nuño United States
April Coan United States
Edward Pequignot
Citations per year, relative to Edward Pequignot Edward Pequignot (= 1×) peers April Coan

Countries citing papers authored by Edward Pequignot

Since Specialization
Citations

This map shows the geographic impact of Edward Pequignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Pequignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Pequignot more than expected).

Fields of papers citing papers by Edward Pequignot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Pequignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Pequignot. The network helps show where Edward Pequignot may publish in the future.

Co-authorship network of co-authors of Edward Pequignot

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Pequignot. A scholar is included among the top collaborators of Edward Pequignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Pequignot. Edward Pequignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Achin, Mercy Gohil, Edward Pequignot, et al.. (2024). HARNESSING POTENT NAÏVE LIKE T CELLS FOR PRECISION CAR T MANUFACTURING. Cytotherapy. 26(6). S135–S135. 1 indexed citations
2.
Chen, Fangfang, David T. Teachey, Edward Pequignot, et al.. (2016). Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy. Journal of Immunological Methods. 434. 1–8. 141 indexed citations
3.
Liu, Xiaojun, Shuguang Jiang, Chongyun Fang, et al.. (2015). Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice. Cancer Research. 75(17). 3596–3607. 425 indexed citations breakdown →
4.
Storey, Philip, Steven Yeh, Edward Pequignot, et al.. (2015). INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 35(10). 1992–2000. 5 indexed citations
5.
Moster, Marlene R., et al.. (2015). Outcomes of Sequential Glaucoma Drainage Implants in Refractory Glaucoma. Journal of Glaucoma. 25(4). e340–e345. 13 indexed citations
6.
Lavu, Harish, Naomi M. Sell, Jordan M. Winter, et al.. (2014). The HYSLAR Trial. Annals of Surgery. 260(3). 445–455. 44 indexed citations
7.
Zhang, Sarah, Benjamin E. Leiby, Edward Pequignot, et al.. (2013). Tumor Recurrence Is Independent of Pancreatic Fistula in Patients after Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Journal of the American College of Surgeons. 217(4). 621–627. 16 indexed citations
8.
Valsecchi, Matías E., Benjamin E. Leiby, Edward Pequignot, et al.. (2012). Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?. BMC Cancer. 12(1). 104–104. 25 indexed citations
9.
Fogh, Shannon, David W. Andrews, Jon Glass, et al.. (2010). Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas. Journal of Clinical Oncology. 28(18). 3048–3053. 254 indexed citations
10.
Keith, Scott W., et al.. (2010). Risk factors associated with urinary albumin excretion in African Americans. Journal of Human Hypertension. 25(1). 3–10. 3 indexed citations
11.
Stoch, S. Aubrey, Cynthia Gargano, J L Valentine, et al.. (2010). Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant. Cancer Chemotherapy and Pharmacology. 67(6). 1313–1321. 13 indexed citations
12.
Malhotra, Prashant, Pranav Sharma, Michael Fishman, et al.. (2009). Clinical, Radiographic, and Audiometric Predictors in Conservative Management of Vestibular Schwannoma. Otology & Neurotology. 30(4). 507–514. 21 indexed citations
13.
Mraović, Boris, et al.. (2008). Preadmission Hyperglycemia is an Independent Risk Factor for In-Hospital Symptomatic Pulmonary Embolism After Major Orthopedic Surgery. The Journal of Arthroplasty. 25(1). 64–70. 75 indexed citations
14.
Seligman, Neil S., et al.. (2008). Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. American Journal of Obstetrics and Gynecology. 199(4). 396.e1–396.e7. 103 indexed citations
15.
Goldman, H. Warren, Robert H. Rosenwasser, M. Beverly Downes, et al.. (2005). Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: An analysis of patients treated at one institution. International Journal of Radiation Oncology*Biology*Physics. 63(1). 82–90. 60 indexed citations
17.
Turner, Bruce, Michelle Ottey, Drazen B. Zimonjic, et al.. (2002). The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.. PubMed. 62(14). 4054–60. 47 indexed citations
18.
Werner‐Wasik, Maria, Ying Xiao, Edward Pequignot, Walter J. Curran, & Walter W. Hauck. (2001). Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial ct scan-based study. International Journal of Radiation Oncology*Biology*Physics. 51(1). 56–61. 100 indexed citations
19.
Werner‐Wasik, Maria, Edward Pequignot, Dennis B. Leeper, Walter W. Hauck, & Walter J. Curran. (2000). Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy. International Journal of Radiation Oncology*Biology*Physics. 48(3). 689–696. 105 indexed citations
20.
Hubbell, Howard R., Hugo E. Vargas, Edward Pequignot, et al.. (1992). Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft. Cancer Immunology Immunotherapy. 35(3). 151–157. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026